United States
Germany
Japan
United Kingdom
China
Rabbit polyclonal antibody to GPR4 (G protein-coupled receptor 4)
| Applications | WB |
| Reactivities | Human (Predicted: Mouse, Rat, Pig, Chimpanzee, Bovine) |
Products
Monkey IgA (Secretory component) goat polyclonal antibody, HRP
| Applications | Tested in immunoelectrophoresis and double radial immunodiffusion against a panel of appropriate secretions and purified immunoglobulin isotypes. In enzyme-immunocytochemical and immunohistochemical staining of free or bound secretory component at the cellular and subcellular level. In non-isotopic assay methodology (e.g. ELISA, Western blotting) in monkey milk or other secretions. This immunoconjugate is not pre-diluted. The optimum working dilution of each conjugate should be established by titration before being used. Excess labelled antibody must be avoided because it may cause high unspecific background staining and interfere with the specific signal. Recommended Working dilutions: Histochemical and cytochemical 1/150 - 1/500. ELISA and comparable non-precipitating antibody-binding assays 1/200 -1/4000. |
| Reactivities | Chimpanzee, Monkey |
| Conjugation | HRP |
Rabbit polyclonal Myosin 1G antibody
| Applications | WB |
| Reactivities | Human, Mouse, Chimpanzee, Rat |
Jagged1 (JAG1) (110-125) rabbit polyclonal antibody, Aff - Purified
| Applications | ELISA, IF, IHC, WB |
| Reactivities | Human, Chimpanzee, Mouse, Rat |
Monkey IgA (Secretory component) goat polyclonal antibody, Azide Free
| Applications | Tested in immunoelectrophoresis and double radial immunodiffusion against a panel of appropriate secretions and purified immunoglobulin isotypes. As unlabelled primary or secondary reagent for indirect detection techniques, to prepare conjugates with markers of the user’s own choice, to prepare an insoluble immunoaffinity adsorbent or a solid phase antibody reagent by coupling to an artificial carrier and as catching or detection antibody in non-isotopic methodology and solid phase immunochemistry. When applied in any cytochemical or histochemical procedure or solids phase coupling technique, the optimum concentration of the IgG preparation should always be established by titration. Working dilutions: Histochemistry: 1/50 - 1/250. ELISA and comparable non-precipitating antibody-binding assays: 1/200 - 1/1000. |
| Reactivities | Chimpanzee, Monkey |
| Conjugation | Unconjugated |
活动过滤器
优化搜索结果
Target Symbol
- SAE1 (3)
- ASAP1 (2)
- CDC27 (2)
- DOPAMINE D2 RECEPTOR (2)
- EGR1 (2)
- GDF15 (2)
- GLG1 (2)
- MYB (2)
- ODF2 (2)
- SLC7A2 (2)
- TRIM29 (2)
- 5HT6 RECEPTOR (1)
- ADGRE5 (1)
- AE2 (1)
- AHA1 (1)
- ALPHA TUBULIN (1)
- AMYLOID PRECURSOR PROTEIN (1)
- ANKRD32 (1)
- APE1 (1)
- ARHGEF11 (1)
- BETA ACTIN (1)
- BORIS (1)
- C-MYC (1)
- C5AR2 (1)
- CAMK4 (1)
- CASPASE 5 (1)
- CASZ1 (1)
- CENPU (1)
- CMTM6 (1)
- CYCLIN B1 (1)
- DMT1 (1)
- DNA PKCS (1)
- DOPAMINE RECEPTOR D3 (1)
- E2F1 (1)
- ECT2 (1)
- EIF3F (1)
- ENTPD2 (1)
- EPHA2 (1)
- ESTROGEN INDUCED GENE 121 PROTEIN (1)
- FAM3C (1)
- FANCA (1)
- FANCC (1)
- FANCF (1)
- FANCG (1)
- FBXO43 (1)
- FBXO9 (1)
- GGA3 (1)
- GLI2 (1)
- GLI3 (1)
- GLUTATHIONE PEROXIDASE 2 (1)
- GPR4 (1)
- HNRNPC (1)
- IL16 (1)
- JAG1 (1)
- KPNA2 (1)
- LDB2 (1)
- LIM KINASE 1 (1)
- MAGP2 (1)
- MTSS1 (1)
- MYOSIN 1G (1)
- NCAPH (1)
- NOTCH2 (1)
- NOXO1 (1)
- NR2E3 (1)
- OLFM4 (1)
- PARK7 (1)
- PGAM1 (1)
- PNK (1)
- POGZ (1)
- PROTEASOME SUBUNIT ALPHA TYPE 6 (1)
- RAB2 (1)
- RB2 P130 (1)
- SELENOPHOSPHATE SYNTHETASE 1 (1)
- SLC39A14 (1)
- SLC44A2 (1)
- SLC5A9 (1)
- SLIT3 (1)
- SPROUTY 4 (1)
- STAT2 (1)
- TA1 (1)
- TATA BINDING PROTEIN (1)
- TCP1 BETA (1)
- TLK1 (1)
- TM9SF3 (1)
- TRIOSEPHOSPHATE ISOMERASE (1)
- TSPAN 13 (1)
- TUBULIN (1)
- WNT7A (1)
- XPO1 (1)
- ZIC2 (1)
Antibody Hosts
Conjugates
Modifications
Clonalities
Assay Types
Families
- Druggable Genome (48)
- Transmembrane (24)
- Transcription Factors (10)
- GPCR (6)
- Stem cell - Pluripotency (6)
- Secreted Protein (4)
- ES Cell Differentiation/IPS (3)
- Embryonic stem cells (3)
- Protein Kinase (3)
- Adult stem cells (2)
- Cancer stem cells (2)
- Protease (2)
- Induced pluripotent stem cells (1)
- Nuclear Hormone Receptor (1)
- Phosphatase (1)
- Stem cell relevant signaling - JAK/STAT signaling pathway (1)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (1)
- Stem cell relevant signaling - Wnt Signaling pathway (1)
Pathways
- Cell cycle (5)
- Neuroactive ligand-receptor interaction (5)
- Pathways in cancer (5)
- Gap junction (4)
- Hedgehog signaling pathway (4)
- Basal cell carcinoma (3)
- Jak-STAT signaling pathway (3)
- Metabolic pathways (3)
- Pathogenic Escherichia coli infection (3)
- Bladder cancer (2)
- Cell adhesion molecules (CAMs) (2)
- Chronic myeloid leukemia (2)
- Glycolysis / Gluconeogenesis (2)
- Lysosome (2)
- Oocyte meiosis (2)
- Regulation of actin cytoskeleton (2)
- Small cell lung cancer (2)
- TGF-beta signaling pathway (2)
- Wnt signaling pathway (2)
- Acute myeloid leukemia (1)
- Adherens junction (1)
- Alzheimer's disease (1)
- Arachidonic acid metabolism (1)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (1)
- Axon guidance (1)
- Basal transcription factors (1)
- Base excision repair (1)
- Calcium signaling pathway (1)
- Chemokine signaling pathway (1)
- Colorectal cancer (1)
- Dilated cardiomyopathy (1)
- Dorso-ventral axis formation (1)
- Endometrial cancer (1)
- ErbB signaling pathway (1)
- Fc gamma R-mediated phagocytosis (1)
- Focal adhesion (1)
- Fructose and mannose metabolism (1)
- Glioma (1)
- Glutathione metabolism (1)
- Huntington's disease (1)
- Hypertrophic cardiomyopathy (HCM) (1)
- Inositol phosphate metabolism (1)
- Leukocyte transendothelial migration (1)
- MAPK signaling pathway (1)
- Melanogenesis (1)
- Melanoma (1)
- NOD-like receptor signaling pathway (1)
- Non-homologous end-joining (1)
- Non-small cell lung cancer (1)
- Notch signaling pathway (1)
- Pancreatic cancer (1)
- Prion diseases (1)
- Progesterone-mediated oocyte maturation (1)
- Prostate cancer (1)
- Proteasome (1)
- Purine metabolism (1)
- Selenoamino acid metabolism (1)
- Spliceosome (1)
- Thyroid cancer (1)
- Tight junction (1)
- Vibrio cholerae infection (1)
- Viral myocarditis (1)
- p53 signaling pathway (1)
